Advertisement
Singapore markets close in 7 hours 41 minutes
  • Straits Times Index

    3,324.50
    +17.06 (+0.52%)
     
  • Nikkei

    38,991.47
    +114.76 (+0.30%)
     
  • Hang Seng

    17,937.84
    0.00 (0.00%)
     
  • FTSE 100

    8,215.48
    +67.67 (+0.83%)
     
  • Bitcoin USD

    68,294.91
    +1,157.59 (+1.72%)
     
  • CMC Crypto 200

    1,450.75
    +55.71 (+3.99%)
     
  • S&P 500

    5,421.03
    +45.71 (+0.85%)
     
  • Dow

    38,712.21
    -35.21 (-0.09%)
     
  • Nasdaq

    17,608.44
    +264.89 (+1.53%)
     
  • Gold

    2,333.30
    -21.50 (-0.91%)
     
  • Crude Oil

    78.27
    -0.23 (-0.29%)
     
  • 10-Yr Bond

    4.2950
    -0.1090 (-2.48%)
     
  • FTSE Bursa Malaysia

    1,611.39
    +2.44 (+0.15%)
     
  • Jakarta Composite Index

    6,850.10
    -6,855.69 (-50.02%)
     
  • PSE Index

    6,410.07
    -48.57 (-0.75%)
     

Looking for Passive Income at a Decent Price? Buy These 2 Stocks

Looking for Passive Income at a Decent Price? Buy These 2 Stocks

Many investors would love to buy passive income stocks with a high dividend yield, a sustainable level of earnings coverage of the dividend, and a cheap valuation. For instance, Zoloft, Xanax, Lyrica, Viagra, and Lipitor are just a few of the older household-name drug brands that Viatris (NASDAQ: VTRS) counts in its portfolio of generic medicines, and while none are new medicines, they're each indispensable to this day. Viatris' forward dividend yield is presently above 5.2%, which is on the high side compared to the market's average yield of around 1.6%.